Insulin Degludec 100IU/ml is an ultra-long-acting type of insulin used to treat types 1 and 2 diabetes mellitus in both adults and children
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Tresiba Flex Touch Prefilled Pen contains Insulin Degludec, an Antidiabetic medication used to manage diabetes mellitus in adults, adolescents, and children aged 1 year and above. It can be used alone or in combination with other antidiabetic medicines for type 2 diabetes and combination with rapid-acting insulin for type 1 diabetes.
Before using the Tresiba Flex Touch Prefilled Pen, inform your doctor about any history of abnormal blood sugar levels, eye disorders, poor eyesight, or liver and kidney problems. Use caution during pregnancy, while planning for pregnancy, or breastfeeding.
It's also advisable to use the Tresiba Flex Touch Prefilled Pen cautiously in children, adolescents, and elderly patients after consulting with a doctor.
Consult your doctor regarding alcohol consumption while using the Tresiba Flex Touch Prefilled Pen to avoid potential low blood sugar levels.
Exercise caution during pregnancy or for women planning to conceive. Seek advice from your doctor before using the medication.
Use the Tresiba Flex Touch Prefilled Pen cautiously while breastfeeding. Consult your doctor before administering the medicine.
Be cautious when driving or operating machinery if you experience symptoms of either low or high blood sugar levels after using the Tresiba Flex Touch Prefilled Pen.
Use the Tresiba Flex Touch Prefilled Pen cautiously in patients with kidney problems. Seek guidance from your doctor before administration.
Exercise caution when using the Tresiba Flex Touch Prefilled Pen in patients with liver issues. Consult your doctor before administering the medication.
Tresiba FlexTouch is indicated for the treatment of both adult and pediatric patients with type 1 and type 2 diabetes mellitus. It works by maintaining a constant level of insulin in the body throughout the day, helping to regulate blood sugar levels and reduce the risk of diabetes-related complications. Tresiba FlexTouch can be used alone or in combination with fast-acting insulin or other diabetic medications.
The primary action of Tresiba FlexTouch, which contains Insulin Degludec, is to control the glucose metabolism system. Insulin Degludec and its analogs lower blood sugar levels by increasing peripheral glucose uptake, particularly by skeletal muscle and fat cells, and by reducing hepatic glucose production. Additionally, Insulin Degludec inhibits lipolysis and proteolysis while promoting protein synthesis. Insulin Degludec forms multihexamers in the subcutaneous tissue when injected subcutaneously, leading to delayed absorption into the systemic circulation. This prolonged action profile is primarily due to the delayed absorption of Insulin Degludec and its binding to circulating albumin.
Ultra-long-acting basal insulin, Insulin Degludec, should be administered once daily at the same time each day.
For patients with type 2 diabetes mellitus, individual dosage adjustments should be made after starting with a dose of 10 units per day.
Type 1 diabetic patients should use Insulin Degludec once daily in addition to mealtime insulin, with individual dosage adjustments as needed.
Insulin Degludec can be used alone or in combination with bolus insulin, GLP-1 receptor agonists, or oral anti-diabetic medications for patients with type 2 diabetes mellitus. For individuals with type 1 diabetes mellitus, Insulin Degludec should be combined with short- or rapid-acting insulin to meet mealtime insulin requirements.
Insulin Degludec provides flexibility in the timing of insulin administration, allowing for injections at different times of the day when necessary. However, there should be a minimum of 8 hours between injections.
If a dose is missed, patients are advised to take it as soon as they remember and then return to their regular once-daily dosing schedule.
Follow your doctor's instructions carefully when administering the Tresiba Flex Touch Prefilled Pen 100IU/ml. Here's how to do it:
Before using the Tresiba Flex Touch Prefilled Pen 100IU/ml, it's crucial to inform your doctor about any medications you are currently taking. This includes:
In case of an accidental overdose of Tresiba Flex Touch Prefilled Pen 100IU/ml, immediate medical attention is necessary. Symptoms of overdose include low blood sugar, characterized by sweating, tiredness, dizziness, increased hunger, and tingling lips.
Intolerance to the active ingredient or any of the excipients in the medication Diabetic retinopathy, hypoglycemia, and hyperglycemia.
Clinical data on the use of insulin degludec in pregnant women are lacking from well-controlled studies. However, animal studies have not shown any differences between human insulin degludec and insulin degludec used in animal reproductive studies regarding embryotoxicity or teratogenicity. The decision to use insulin degludec during pregnancy should only be made if the benefits outweigh the risks.
The use of insulin degludec during breastfeeding has not been studied in controlled clinical settings. Whether insulin degludec is excreted in human milk is unknown.
Store insulin degludec in a refrigerator at 2°C to 8°C. Do not freeze. If needed for immediate use, it can be kept in a cool place away from heat and light. Once in use, insulin degludec can be stored at room temperature for up to a month.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.